title: Relationship between CD45 antigen expression and putative stages of differentiation in B-cell malignancies.
abstract: The cell-surface antigen CD45 is a complex family of high-molecular-weight glycoproteins expressed on all lymphohematopoietic cells, but not in the same molecular isoform. This antigen complex is known to exhibit protein tyrosine phosphatase (PTPase) activity and appears to have a role in regulation of cell differentiation. In that CD45 expression parallels stages of differentiation in normal bone marrow B cells, it was of interest to evaluate this process in malignant B cells. Monoclonal antibodies (MoAbs) were used to investigate the quantitative expression of CD45 and CD45RA on the B cells of lymphoid leukemias. Employing standardized flow cytometric methods, it was found that the fluorescence intensity (FI) of immunostained malignant B cells, as a reflection of the antigen content, demonstrated correlations with the putative stage of cell differentiation for malignancies at the earlier stages, but at the later stages, a progressive loss of CD45 was observed. Since this antigen family has been found to display PTPase activity, further investigation of CD45 alterations in malignancies may provide insight into potential regulatory disturbances.
authors.affiliation: Department of Pathology, University of Missouri School of Medicine, Columbia 65212.
authors.forename: C W
authors.initials: CW
authors.lastname: Caldwell
authors.forename: W P
authors.initials: WP
authors.lastname: Patterson
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal; D000943:Antigens, Differentiation / Q000276:immunology / Q000378:metabolism* / Q000502:physiology; D001402:B-Lymphocytes / Q000473:pathology*; D002454:Cell Differentiation / Q000502:physiology; D002471:Cell Transformation, Neoplastic / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D002648:Child; D002675:Child, Preschool; D005434:Flow Cytometry; D005453:Fluorescence; D006649:Histocompatibility Antigens / Q000276:immunology / Q000378:metabolism* / Q000502:physiology; D006801:Humans; D007150:Immunohistochemistry; D007536:Isomerism; D007943:Leukemia, Hairy Cell / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D007952:Leukemia, Plasma Cell / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D015463:Leukemia, Prolymphocytic / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D017493:Leukocyte Common Antigens; D008875:Middle Aged; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000276:immunology / Q000378:metabolism* / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D000943:Antigens, Differentiation; D006649:Histocompatibility Antigens; D017493:Leukocyte Common Antigens; D010727:Phosphoric Diester Hydrolases; C025672:RNA-tyrosine phosphatase